News
Bristol Myers Squibb Receives Positive CHMP Opinion for Inrebic for Adult Patients with Newly Diagnosed and Previously Treated Myelofibrosis
Bristol Myers Squibb announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Inrebic® (fedratinib)...
News
First COVID-19 vaccine shipments arrive in Canada, more en route
Some of the country's initial 30,000 doses of the Pfizer-BioNTech vaccines touched down on Sunday night, Prime Minister Justin Trudeau announced on Twitter, sharing a...
Clinical Trials
Novartis provides update on RUXCOVID study of ruxolitinib for hospitalized patients with COVID-19
Novartis announced that the Phase III RUXCOVID study evaluating ruxolitinib on top of standard of care (SoC) therapy compared to SoC treatment alone in patients...
News
Saudi Arabia approves Pfizer-BioNTech coronavirus vaccine
Saudi Arabia approved the use of the Pfizer-BioNTech novel coronavirus vaccine, state media reported, becoming the second Gulf country after Bahrain to green-light the drug.
"The...
News
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
ERT, a global leader in clinical end-point data solutions, announced that Bioclinica, a technological and scientific leader in clinical imaging, has agreed to merge with...
Clinical Trials
Sinovac snags $515M investment to double COVID-19 vaccine capacity as phase 3 readout nears
As the various COVID-19 vaccines move closer to the finish line, their developers have been raising money from investors or through advance government purchases to...
News
Sinovac Announces Product License for 23-Valent Pneumococcal Polysaccharide Vaccine
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that the China National Medical Products Administration (NMPA) has approved and issued a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.